Related Experiment Videos
Rapid and efficient retrovirus-mediated gene transfer into B cell lines
1The University of British Columbia, Department of Microbiology and Immunology, Vancouver, Canada.
Summary
This study presents a rapid retroviral gene transfer method for murine B cell lines, significantly accelerating research. This efficient technique allows for pure cell populations expressing exogenous genes within days, speeding up studies on B cell signaling and function.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Murine B cell lines (WEHI-231, BAL17, M12.4.1) are crucial models for studying cellular processes.
- Gene expression studies in these cell lines are often hindered by inefficient electroporation methods.
- Current methods require weeks for clone isolation and cell expansion for experiments.
Purpose of the Study:
- To develop and optimize a rapid retroviral-mediated gene transfer protocol for murine B cell lines.
- To significantly reduce the time required to obtain pure populations of genetically modified B cells.
- To facilitate expedited research in B cell signal transduction, cell cycle regulation, and apoptosis.
Main Methods:
- Utilized retroviral vectors for gene delivery into WEHI-231, BAL17, and M12.4.1 cell lines.
- Infected cells and assessed exogenous gene expression levels at 2 days post-infection.
- Applied puromycin selection to isolate pure populations of successfully transduced cells.
- Expanded transduced cells for subsequent biochemical analyses.
Main Results:
- Achieved efficient exogenous gene expression in murine B cell lines within 4 days.
- Reported gene expression rates ranging from 10% (BAL17, M12.4.1) to 70% (WEHI-231) at 2 days post-infection.
- Demonstrated successful isolation of pure, gene-expressing cell populations using puromycin selection.
- Confirmed sufficient cell numbers for biochemical experiments after 5-7 days of expansion.
Conclusions:
- The optimized retroviral gene transfer method is rapid and efficient for murine B cell lines.
- This protocol significantly shortens the timeline for generating genetically modified B cells.
- The method facilitates accelerated research into B cell signaling, cell cycle, and apoptosis.